converge
schering-plough animal health limited - levamisole hydrochloride; abamectin; cobalt present as disodium cobalt edta; selenium present as sodium selenate - levamisole hydrochloride 80 g/litre; abamectin 2 g/litre; cobalt present as disodium cobalt edta 5 g/litre; selenium present as sodium selenate 1 g/litre - endoparasiticide
alliance
schering-plough animal health limited - levamisole hydrochloride; selenium present as sodium selenate; cobalt present as disodium cobalt edta; abamectin; oxfendazole - levamisole hydrochloride 80 g/litre; selenium present as sodium selenate 2.4 g/litre; cobalt present as disodium cobalt edta 5 g/litre; abamectin 2 g/litre; oxfendazole 45.3 g/litre - oral nutrient/electrolyte
leventa
schering-plough animal health limited - levothyroxine sodium pentahydrate - levothyroxine sodium pentahydrate 1 g/litre - endocrine agent (hormone)
posatex
schering-plough animal health limited - mometasone furoate monohydrate; posaconazole; orbifloxacin - mometasone furoate monohydrate 1 g/kg; posaconazole 1 g/kg; orbifloxacin 10 g/kg - antibiotic
porcilis pcv m hyo
schering-plough animal health limited - mycoplasma hyopneumoniae; porcine circovirus type 2 orf-2 protein - mycoplasma hyopneumoniae 0 vaccine; porcine circovirus type 2 orf-2 protein 0 vaccine - vaccine
bravecto plus
schering-plough animal health limited - fluralaner; moxidectin - fluralaner 280 g/litre; moxidectin 14 g/litre - endoparasiticide
nobivac canine oral bb
schering-plough animal health limited - bordetella bronchiseptica (attenuated) - bordetella bronchiseptica (attenuated) 0 vaccine - vaccine
shutout
schering-plough animal health limited - bismuth subnitrate - bismuth subnitrate 650 g/kg - teat sealant
bravecto quantum
schering-plough animal health limited - fluralaner - fluralaner 150 g/litre - ectoparasiticide
temodal temozolomide 250mg capsule sachet
merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 250 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; lactose; stearic acid; gelatin; titanium dioxide; sodium starch glycollate; tartaric acid; colloidal anhydrous silica; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.